Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by The PERT Consortium™

evt | Article | July 2024 Supplement

PERT International: Enhancing Patient Outcomes Globally

Establishing National PERT networks in Europe and around the world.

By Mona Ranade, MD; Mahir Elder, MD, FACC, FSCAI; and Stavros Konstantinides, MD

evt | Article | September 2016

Radial Access in Patients on Anticoagulation

Is transradial access safe in anticoagulated or coagulapathic patients undergoing noncoronary endovascular interventions?

By Mona Ranade, MD, and Aaron Fischman, MD

evt | Article | August 2024

Streamlining DVT/CVO Management

A discourse on the varied treatment algorithms at centers in the United States.

With Steven Abramowitz, MD; Mona Ranade, MD; Wendy Nelson, NP; and S. Jay Mathews, MD, MS, FACC, FSCAI

Sponsored by The PERT Consortium™

evt | Article | July 2023 Supplement

Pulmonary Embolism Clinical Trial Updates

Trial principal investigators provide insight into and updates to the APEX-AV, PE-TRACT, HI-PEITHO, and STORM-PE studies.

With Mona Ranade, MD; Akhilesh Sista, MD, FSIR, FAHA; Stavros V. Konstantinides, MD; Kenneth Rosenfield, MD, MHCDS; and Rachel P. Rosovsky, MD, MPH

Advertisement

Advertisement

Sponsored by AngioDynamics, Inc.

evt | Article | May 2022

Case Report: Use of the AlphaVac System for the Removal of Right Atrial Thrombus

By Mona Ranade, MD, and John M. Moriarty, MD, FSIR, FSVM

evt | Article | January 2026

What’s on Your Pulmonary Embolism Trial Wishlist?

Insights on what’s needed to advance diagnosis, treatment decision-making, and outcomes.

With Pavan K. Kavali, MD; Mona Ranade, MD; and Amir Darki, MD, MSc

Sponsored by The PERT Consortium™

evt | Article | July 2022 Supplement

Rationale for the APEX-AV, HI-PEITHO, and PE-TRACT Trials

A review of the objectives, study design, outcome measures, and potential impact of three upcoming pulmonary embolism studies.

By Mona Ranade, MD; Peter Monteleone, MD; and Akhilesh K. Sista, MD

evt | Article | August 2023

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

Sponsored by The PERT Consortium™

evt | Article | July 2024 Supplement

Enhancing Pulmonary Embolism
Treatment: Insights From the APEX-AV Study on the AlphaVac F1885 Catheter

A summary of the study’s findings and their implications on managing patients with acute intermediate-risk PE.

By Brent Keeling, MD; Mona Ranade, MD; and Seth Sokol, MD

evt | Article | July 2023

Decision-Making in Submassive Pulmonary Embolism

Insights into the current state of the PE data, how to decide whether to approach mechanically and with what devices, when ECMO may be beneficial, and knowing when extraction is successful and stopping the procedure.

With Vladimir Lakhter, DO, FSVM; Gerard O'Sullivan, MD; Mona Ranade, MD; Akhilesh Sista, MD, FSIR, FAHA

evt | Article | January 2025

Adopting New DVT Tools: What Are the Key Questions to Ask Beforehand?

An assessment of essential considerations for clinicians adopting new DVT tools, focusing on efficacy, safety, and integration into existing protocols to ensure effective and safe adoption.

By Pedram Keshavarz, MD; Jonas Kruse, MD; John M. Moriarty, MD, FSIR; and Mona Ranade, MD

evt | Article | July 2025

PE in Prime Time: New Pathways, Devices, and Trials

A comprehensive conversation about the state of pulmonary embolism care today, including keys to a strong program, use of artificial intelligence, typical interventional pathways, approaches to trial enrollment, and more.

With Gregory Piazza, MD, MS; Akhilesh Sista, MD, FSIR, FAHA; Brent Keeling, MD; Saher Sabri, MD; and Mona Ranade, MD

evt | News | January 13, 2025

AngioDynamics’ AlphaVac F1885 System’s APEX-AV Trial Results Published

January 13, 2025—AngioDynamics, Inc. announced that the results from the APEX-AV trial, which evaluated acute pulmonary embolism (PE) extraction with the company’s AlphaVac F18⁸⁵ system, were published by Mona Ranade, MD, et al online in JSCAI, the Journal of the Society for Cardiovascular Angiography & Interventions.

evt | Article | July 2025

Current Concepts in Venous Care

By Kathleen Gibson, MD

evt | News | April 27, 2022

AngioDynamics Launches APEX-AV Study in Partnership with PERT Consortium

April 27, 2022—AngioDynamics, Inc. announced the launch of APEX-AV, the “Acute Pulmonary Embolism Extraction Trial with the AlphaVac System” clinical study, which is aimed at evaluating the efficacy and safety of the company’s AlphaVac multipurpose mechanical aspiration (MMA) F1885 system in the treatment of acute intermediate-risk pulmonary embolism (PE).

evt | Article | August 2024

Algorithmic Approaches

By Nicolas J. Mouawad, MD

evt | Article | July 2023

Directions in Venous Care

By Karem Harth, MD, MHS, RPVI, and Marie Josee van Rijn, MD, PhD

evt | Article | January 2025

Optimizing Deep Venous Treatment

By Suresh Vedantham, MD

evt | News | April 4, 2024

AngioDynamics’ AlphaVac F18⁸⁵ System Receives FDA Clearance for Treatment of PE

April 4, 2024—AngioDynamics, Inc. announced FDA 510(k) clearance for the AlphaVac F1885 system for the treatment of pulmonary embolism (PE).

evt | News | October 31, 2022

AngioDynamics Commences APEX-AV Study to Assess AlphaVac F18⁸⁵ System in Treatment of PE

October 31, 2022—AngioDynamics, Inc. announced the enrollment of the first patient in the “Acute Pulmonary Embolism Extraction Trial With the AlphaVac System” (APEX-AV) clinical study at Jacobi Medical Center in New York, New York.


1
2

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button